BioMarin Pharmaceuticals
BMRN
BMRN
391 hedge funds and large institutions have $21.6B invested in BioMarin Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 155 increasing their positions, 128 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 377 → 391 (+14)
0% more funds holding in top 10
Funds holding in top 10: 16 → 16 (0)
Holders
391
Holding in Top 10
16
Calls
$329M
Puts
$294M
Top Buyers
| 1 | +$270M | |
| 2 | +$161M | |
| 3 | +$85M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$78.2M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$73.6M |
Top Sellers
| 1 | -$96.8M | |
| 2 | -$92.3M | |
| 3 | -$74.4M | |
| 4 |
VAM
Visium Asset Management
New York
|
-$72.8M |
| 5 |
TG
TCW Group
Los Angeles,
California
|
-$64.9M |